Back to Report Store Home

Global Women’s Health Drugs Market to 2024 – Influx of New Products Including Orilissa, Relugolix and Bremelanotide to Diversify Landscape and Drive Growth

  • Published: Jan-2019
  • Report Code: GBIHC488MR
  • Report Format: pdf

Description

List of Tables

Table 1: Women’s Health Drugs Market, Global, Classification of Cervical Intraepithelial Neoplasia, 2018

Table 2: Women’s Health Drugs Market, Common Symptoms of the Perimenopause and Menopause, 2018

Table 3: Women’s Health Drugs Market, Global, Comparison of PCOS Diagnostic Criteria Classification Systems, 2018

Table 4: Women’s Health Drugs Market, 7MM, Prevalence of Endometriosis, Polycystic Ovarian Syndrome, and Women’s Infertility, 2017

Table 5: Women’s Health Drugs Market, Global, Types of Female Contraceptives, 2018

Table 6: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Premarin, 2018

Table 7: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Lupron/Lupron Depot, 2018

Table 8: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Gonal-F, 2018

Table 9: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Mirena, 2018

Table 10: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Celebrex, 2018

Table 11: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Implanon ,2018

Table 12: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Yasmin/Yaz, 2018

Table 13: Women’s Health Drugs Market, Global, Approved Health Indications for Nuvaring, 2018

Table 14: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Gardasil, 2018

Table 15: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Esmya, 2018

Table 16: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Orilissa, 2018

Table 17: Women’s Health Drugs Market, Global, Annual Revenue Forecast for Key Products ($m), 2017–2024 (part 1)

Table 18: Women’s Health Drugs Market, Global, Annual Revenue Forecast for Key Products ($m), 2017–2024 (part 2)

Table 19: Women’s Health Drugs Market, Global, Forecast Revenue by Company, 2017–2024

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards